A multinational survey assessing the impact and burden of pruritus on patients with primary sclerosing cholangitis

Cholestatic pruritus in PSC has a major adverse impact on QoL, interferes with daily activities, and is inadequately treated in the majority of respondents. These unmet needs highlight the importance of developing safe/effective antipruritic treatments for PSC.